Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alcon couvreur - prednisolone, sulfacetamide - eye ointment - 10, 0.25 %

Mesir - Inggeris - EDA (Egyptian Drug Authority)

alcon-scientific office - eye ointment

Mesir - Inggeris - EDA (Egyptian Drug Authority)

alcon belgium - eye drops

Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alcon couvreur - prednisolone, sulfacetamide - eye drops - 10, 0.25, 0.5 %

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

electramed ireland limited - prednisolone acetate sulfacetamide sodium -

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - prednisolone acetate 2,5 mg/ml; sulfacetamide sodium 100 mg/ml - eye drops, suspension - prednisolone and antiinfectives

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

carsl consulting - clonidine 2.5mg - transdermal patch - 2.5 mg - active: clonidine 2.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

carsl consulting - clonidine 5mg - transdermal patch - 5 mg - active: clonidine 5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

carsl consulting - clonidine 7.5mg - transdermal patch - 7.5 mg - active: clonidine 7.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - clonidine hydrochloride, quantity: 150 microgram/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - indications as at 16 may 2001: parenteral: acute hypertensive crisis. as an alternative to oral therapy where the oral route of administration is inappropriate.